Los Angeles, Calif. – A recently published human clinical study has shown that thymic protein A, when delivered as an oral powder, is significantly effective at relieving symptoms associated with Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS).
The study, “Improved Immune Activation Markers in Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS) Patients Treated with Thymic Protein A”, conducted by Dr. Michael Rosenbaum et al, and published in the December 2001 issue of the Journal of Nutritional and Environmental Medicine1, was designed to determine if the oral administration of thymic protein A would produce noticeable results in patients suffering from CFIDS. The study was funded by Longevity Science and Genicel Inc., makers of the patented thymic protein A supplement “ProBoost™.”
Rosenbaum’s breakthrough study offers new hope to individuals suffering from CFIDS. Sixteen of the 23 patients in the study showed marked improvement in immune system function, with a corresponding improvement of the clinical symptoms of CFIDS.
“This study suggests that the restoration of proper immune regulation with thymic protein A can ameliorate symptoms associated with CFIDS,” said Rosenbaum. Data obtained from the study showed improvement in various blood markers used to diagnose CFIDS, including specific T-cell counts and increased white blood cell counts.
Many patients also reported dramatic improvements in the symptoms associated with CFIDS: These improvements included: 47% in sleep quality, 43% reduction of food sensitivities, 53% reduction of chemical sensitivities, 47% improvement in short term memory, 79% improvement in depression, 100% improvement in panic reactions, as well as similar improvement s in sore throat frequency, swollen lymph glands, nasal allergies, muscle weakness, anxiety, and canker sores.
There are currently more than 800,000 people suffering from CFIDS in the United States, and fifty percent of these afflicted individuals are disabled and unable to work. CFIDS is characterized by unexplained, persistent fatigue that interferes with the ability to carry out normal daily activities. Researchers have also found that many patients suffering from CFIDS have elevated titers to viruses such as Epstein-Barr, Cytomegalovirus, and Human Herpes Virus 6.
“ProBoost thymic protein A offers everyone an effective, safe and natural way to improve immune function”, said Klabin. “ProBoost contains the identical thymic protein that is depleted in humans due to the inevitable shrinkage of the thymus gland which begins at puberty. The loss of thymic function results in a lowering of immune readiness and reduced ability to handle infectious agents when they attack the body. Thymic protein A acts as a potent immune regulator, by activating the key T-4 helper white blood cells and restoring immune function. We believe that this restoration of proper immunity caused the significant improvement in CFIDS symptoms of a majority of the participants in this study.”
ProBoost is available from Longevity Science, a dietary supplement company serving health care professionals and the public. For more information on ProBoost call 1-800-933-9440.
# # #
1Rosenbaum, M. E., Vojdani, A., Susser, M., Watson, C.M. Improved immune activation markers in chronic fatigue and immune dysfunction syndrome (CFIDS) patients treated with thymic protein A. Journal of Nutritional & Environmental Medicine 2001; 11: 241-7.